Skip to main content
Clinical Trials/CTRI/2022/06/043426
CTRI/2022/06/043426
Completed
未知

Periodontal Regeneration by application ofParticulate Dentin Graft (PDG) with Recombinant Human Platelet-Derived Growth Factor (RHPDGF) in human periodontal infrabony defects: An In-Vivo and In-VitroEvaluation

Indian Council of Medical Research0 sites29 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Indian Council of Medical Research
Enrollment
29
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 16, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Teeth without root canal fillings that are extracted due to advanced periodontal bone loss or fractures which have a hopeless prognosis.
  • 2\. Patient with moderate to severe chronic periodontitis with no other systemic disease.
  • 3\. Presence of deep infra\-bony defect with a probing depth of \>5 mm at baseline.
  • 4\. Presence of infra\-bony component of at least 3 mm as detected on the radiograph.
  • 5\. Patients with a good level of oral hygiene with Plaque Index (PI, Loe and Sillness).

Exclusion Criteria

  • 1\. Root canal treated teeth
  • 2\. Patients with systemic disease discovered on routine investigations during the study
  • (such as diabetes mellitus, hypertension, etc.) which could influence the outcome of the
  • 3\. Pregnant and lactating mothers or those planning a pregnancy.
  • 4\. History within the last 6 months of oral cancer or human immunodeficiency virus (HIV).
  • 5\. Patients with life threatening disease
  • 6\. History of previous periodontal surgery on the study tooth within the last year;
  • 7\. Patients with bleeding disorders.
  • 8\. Patients suffering from allergic conditions or a history of allergies.
  • 9\. Patients on long\-term antibiotics.

Outcomes

Primary Outcomes

Not specified

Similar Trials